International Companies Entering the US Market
The Challenges We Solve
The U.S. healthcare system is uniquely complex and fragmented. International organizations often underestimate the importance of reimbursement models, provider incentives, and outcomes data in achieving adoption.
Organizations frequently struggle with →
Understanding the structure of the U.S. healthcare system
Identifying viable market entry points
Navigating payer, employer, and provider stakeholders
Demonstrating measurable clinical and economic value that aligns with the goals of the patients and those subsidizing care delivery
Understanding competitive dynamics in crowded digital health categories
Fitting into the economic models of value-based and fee-for-service reimbursement
How JB Advisory helps
JB Advisory helps international healthcare companies navigate the U.S. market with strategies grounded in real-world healthcare economics.
We provide support across →
U.S. healthcare market education and orientation
Market entry and commercialization strategy
Competitive landscape and positioning analysis
Value-based reimbursement alignment
Truly differentiated outcomes measurement and clinical impact frameworks
Our goal is to help global healthcare innovators successfully adapt their solutions to the realities of the U.S. healthcare ecosystem.
